What is CASI Pharmaceuticals Inc Quarterly Revenue?

CASI Pharmaceuticals Inc Quarterly Revenue CASI Pharmaceuticals Inc Dec-2024 Quarterly Revenue is $13 Million which is growth of 94.3% YoY.

What is CASI Pharmaceuticals Inc Quarterly Net Profit?

CASI Pharmaceuticals Inc Quarterly Net Profit CASI Pharmaceuticals Inc Dec-2024 Quarterly Net Profit is $-14 Million which is growth of -137.3% YoY.

What is CASI Pharmaceuticals Inc Annual Revenue?

CASI Pharmaceuticals Inc Annual Revenue CASI Pharmaceuticals Inc Dec-2024 Annual Revenue is $29 Million which is growth of -15.8% YoY.

What is CASI Pharmaceuticals Inc Annual Net Profit?

CASI Pharmaceuticals Inc Annual Net Profit CASI Pharmaceuticals Inc Dec-2024 Annual Net Profit is $-39 Million which is growth of -45.7% YoY.

What is CASI Pharmaceuticals Inc Total Shareholders Fund?

CASI Pharmaceuticals Inc Total Shareholders Fund CASI Pharmaceuticals Inc Dec-2024 Total Shareholders Fund is $2 Million which is growth of -92.3% YoY.

What is CASI Pharmaceuticals Inc Total Assets?

CASI Pharmaceuticals Inc Total Assets CASI Pharmaceuticals Inc Dec-2024 Total Assets is $54 Million which is growth of -28.7% YoY.

What is CASI Pharmaceuticals Inc Book Value Per Share?

CASI Pharmaceuticals Inc Book Value Per Share CASI Pharmaceuticals Inc Book Value Per Share is $0 which is growth of -94.4% YoY.

What is CASI Pharmaceuticals Inc ROE?

CASI Pharmaceuticals Inc ROE CASI Pharmaceuticals Inc ROE is 0% which is growth of 0% YoY.

What is CASI Pharmaceuticals Inc Cash From Operating Activity?

CASI Pharmaceuticals Inc Cash From Operating Activity CASI Pharmaceuticals Inc Dec-2024 Cash From Operating Activity is $-29 Million which is growth of -46.4% YoY.

What is CASI Pharmaceuticals Inc Net Cash Flow?

CASI Pharmaceuticals Inc Net Cash Flow CASI Pharmaceuticals Inc Dec-2024 Net Cash Flow is $-3 Million which is growth of 91.7% YoY.

CASI Pharmaceuticals Inc Quarterly Results and Financial Statement as of Dec, 2024

CASI Pharmaceuticals Inc

XNAS: CASI

Download real time

1.95 0.04 (2.09%)

New 52W Low in past week

3,881 XNAS Volume

XNAS 11 Apr, 2025 5:30 PM (EDT)

Board Meeting

The latest board meeting for CASI Pharmaceuticals Inc took place on 11 Apr 2025, for the purpose of CASI Pharmaceuticals Inc Annual General Meeting for 2024 See details

New 52W Low in past week

CASI Pharmaceuticals Inc quarterly, annual results, revenue, profit, P&L, Balance Sheet, Cash Flow, Annual Reports, Margins - 15 Years history